2021 American Transplant Congress
Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
1OPTN DTAC, Richmond, VA, 2UNOS, Richmond, VA
*Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…2021 American Transplant Congress
Clinical Features and Outcomes of Candidemia in Patients with Left Ventricular Assist Devices
Infectious Diseases, Washington University School of Medicine, St Louis, MO
*Purpose: Fungal infections represent an uncommon etiology of Left Ventricular Assist Device (LVAD) infections but can lead to significant morbidity and mortality. In this study,…2021 American Transplant Congress
Evaluate the Effect of Cresemba (isavuconazonium Sulfate) Capsule and Noxafil (posaconazole) Delayed Release Tablets on Tacrolimus Dose to Concentration (D/C) Ratios in Lung Transplant Recipients
*Purpose: Evaluate the effect of Cresemba (isavuconazonium sulfate) capsule and Noxafil (posaconazole) delayed release tablet on tacrolimus dose to concentration (D/C) ratio in lung transplant.*Methods:…2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…2020 American Transplant Congress
Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients
*Purpose: Voriconazole is the drug of choice for prophylaxis and treatment of Aspergillus infection in lung transplant ( LTx) recipients. Voriconazole has a narrow therapeutic…2020 American Transplant Congress
Evaluation of SUBA-Itraconazole Use in Lung Transplant Recipients
*Purpose: Itraconazole (IT) is commonly used after lung transplant for fungal prophylaxis, particularly in those with a history of skin cancer, concern for Histoplasmosis infection,…2020 American Transplant Congress
Alternate Triazole Therapy for Breakthrough Invasive Fungal Disease in Lung Transplant Recipients on Triazole Prophylaxis
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Invasive fungal diseases (IFD) are a leading cause of infection related morbidity and mortality in lung transplant (LT) recipients. Data regarding outcomes of breakthrough…2020 American Transplant Congress
Epidemiology of Invasive Candidiasis in Lung Transplant Recipients at a Large Transplant Center
*Purpose: Invasive candidiasis (IC) represents the most common fungal infection in lung transplant recipients (LTR) early post-transplant. Universal antifungal prophylaxis is frequently employed, which may…2020 American Transplant Congress
Epidemiology of Non-Aspergillus Mold in Lung Transplant Recipients at a Large Transplant Center
*Purpose: Invasive fungal infections (IFI) remain a significant cause of mortality among lung transplant recipients (LTR). The emergence of non-Aspergillus molds has become a concern…2020 American Transplant Congress
Isavuconazole (ISA) versus Voriconazole (VOR) Prophylaxis (px) in Lung Transplant Recipients (LTR)
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: IFI is a significant complication following lung transplant (LT). VOR was universal antifungal (AF) px in our LT program from 2004-09/2015, at which time…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 10
- Next Page »